Bradley Herring - 26 Feb 2025 Form 4 Insider Report for Enfusion, Inc. (ENFN)

Role
Chief Financial Officer
Signature
/s/ Matthew Campobasso, as Attorney-in-Fact
Issuer symbol
ENFN
Transactions as of
26 Feb 2025
Transactions value $
$0
Form type
4
Filing time
28 Feb 2025, 16:05:13 UTC
Previous filing
10 Jan 2025
Next filing
05 Mar 2025
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ENFN Class A Common Stock Award $0 +58,202 +22% $0 324,571 26 Feb 2025 Direct F1
transaction ENFN Class A Common Stock Award $0 +6,296 +1.9% $0 330,867 26 Feb 2025 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Consists of restricted stock units ("RSUs") awarded pursuant to the Enfusion, Inc. 2021 Stock Option and Incentive Plan (the "Plan"). The RSUs will vest in full as follows: 19,401, 19,401 and 19,400 on each of February 26, 2026, 2027 and 2028.
F2 Consists of fully vested shares issued under the Plan.